Cigna Group Financials

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 51/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Cigna Group has an operating margin of 3.8%, meaning the company retains $4 of operating profit per $100 of revenue. This below-average margin results in a low score of 19/100, suggesting thin profitability after operating expenses. This is down from 4.4% the prior year.

Growth

100

Cigna Group's revenue surged 26.6% year-over-year to $247.1B, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

Cigna Group carries a low D/E ratio of 0.71, meaning only $0.71 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Cigna Group's current ratio of 0.84 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 14/100, which could limit financial flexibility.

Returns

Cigna Group's ROE of 9.2% shows moderate profitability relative to equity, earning a score of 37/100. This is down from 11.6% the prior year.

Altman Z-Score Grey Zone

2.51

Cigna Group scores 2.51, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

6/9

Cigna Group passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.74x

For every $1 of reported earnings, Cigna Group generates $2.74 in operating cash flow ($10.4B OCF vs $3.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

6.3x

Cigna Group earns $6.3 in operating income for every $1 of interest expense ($9.4B vs $1.5B). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

This page shows Cigna Group (CI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$247.1B

YoY+26.6%

5Y CAGR+10.0%

Cigna Group generated $247.1B in revenue in fiscal year 2024. This represents an increase of 26.6% from the prior year.

EBITDA

$12.2B

YoY+5.4%

5Y CAGR+0.8%

Cigna Group's EBITDA was $12.2B in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.4% from the prior year.

Free Cash Flow

N/A

Net Income

$3.8B

YoY-29.7%

5Y CAGR-5.9%

Cigna Group reported $3.8B in net income in fiscal year 2024. This represents a decrease of 29.7% from the prior year.

EPS (Diluted)

$12.12

YoY-30.3%

5Y CAGR-2.0%

Cigna Group earned $12.12 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 30.3% from the prior year.

Cash & Debt

$7.5B

YoY-3.5%

5Y CAGR+10.3%

Cigna Group held $7.5B in cash against $28.9B in long-term debt as of fiscal year 2024.

Dividends Per Share

$5.60

YoY+13.8%

5Y CAGR+168.7%

Cigna Group paid $5.60 per share in dividends in fiscal year 2024. This represents an increase of 13.8% from the prior year.

Shares Outstanding

274M

YoY-6.4%

5Y CAGR-6.0%

Cigna Group had 274M shares outstanding in fiscal year 2024. This represents a decrease of 6.4% from the prior year.

Gross Margin

N/A

Operating Margin

3.8%

YoY-0.6pp

5Y CAGR-1.4pp

Cigna Group's operating margin was 3.8% in fiscal year 2024, reflecting core business profitability. This is down 0.6 percentage points from the prior year.

Net Margin

1.5%

YoY-1.2pp

5Y CAGR-1.8pp

Cigna Group's net profit margin was 1.5% in fiscal year 2024, showing the share of revenue converted to profit. This is down 1.2 percentage points from the prior year.

Return on Equity

9.2%

YoY-2.4pp

5Y CAGR-2.1pp

Cigna Group's ROE was 9.2% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 2.4 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

$7.0B

YoY+208.0%

5Y CAGR+28.8%

Cigna Group spent $7.0B on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 208.0% from the prior year.

Capital Expenditures

N/A

CI Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$247.1B+26.6%	$195.3B+8.2%	$180.5B+3.7%	$174.1B+8.5%	$160.4B+4.5%	$153.6B
Cost of Revenue	$182.5B+36.4%	$133.8B+7.2%	$124.8B+6.2%	$117.6B+13.6%	$103.5B+6.0%	$97.7B
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$14.8B+0.1%	$14.8B+12.5%	$13.2B+1.2%	$13.0B-7.5%	$14.1B+0.1%	$14.1B
Operating Income	$9.4B+10.3%	$8.5B+1.0%	$8.4B+6.4%	$7.9B-2.6%	$8.2B+0.9%	$8.1B
Interest Expense	$1.5B+7.1%	$1.4B+7.7%	$1.3B0.0%	$1.3B-7.1%	$1.4B-12.5%	$1.6B
Income Tax	$1.5B+957.4%	$141.0M-91.3%	$1.6B+17.9%	$1.4B-42.4%	$2.4B+64.1%	$1.4B
Net Income	$3.8B-29.7%	$5.4B-20.8%	$6.8B+25.1%	$5.4B-36.2%	$8.5B+65.8%	$5.1B
EPS (Diluted)	$12.12-30.3%	$17.39-18.8%	$21.41+35.9%	$15.75-31.4%	$22.96+70.8%	$13.44

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$69.7B+3.8%	$67.2B+2.6%	$65.5B-0.2%	$65.6B+8.5%	$60.5B+5.7%	$57.3B+12.0%	$51.1B+4.2%	$49.0B
Cost of Revenue	$55.5B+4.2%	$53.3B+10.1%	$48.4B-1.3%	$49.0B+10.2%	$44.5B+7.4%	$41.4B+17.5%	$35.3B+4.8%	$33.6B
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$3.4B-2.1%	$3.4B-18.5%	$4.2B+9.0%	$3.9B+4.9%	$3.7B-0.6%	$3.7B-8.8%	$4.1B+7.2%	$3.8B
Operating Income	$2.6B+11.8%	$2.3B+17.0%	$2.0B-9.3%	$2.2B-9.9%	$2.4B+6.9%	$2.3B+9.5%	$2.1B-8.0%	$2.2B
Interest Expense	$363.0M+7.4%	$338.0M-6.6%	$362.0M-2.9%	$373.0M-1.3%	$378.0M+2.4%	$369.0M+4.8%	$352.0M-0.3%	$353.0M
Income Tax	$322.0M-17.2%	$389.0M+62.8%	$239.0M-49.5%	$473.0M+31.4%	$360.0M+23.7%	$291.0M+131.7%	-$919.0M-335.0%	$391.0M
Net Income	$2.0B+20.9%	$1.6B+15.8%	$1.4B-8.3%	$1.5B-5.7%	$1.6B+868.4%	-$212.0M-119.2%	$1.1B-23.6%	$1.4B
EPS (Diluted)	$6.98+22.2%	$5.71+17.7%	$4.85-3.2%	$5.01-8.1%	$5.45+661.9%	$-0.97-127.8%	$3.49-26.4%	$4.74

CI Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$155.9B+2.0%	$152.8B+6.2%	$143.9B-7.1%	$154.9B-0.4%	$155.5B-0.2%	$155.8B
Current Assets	$48.9B+30.8%	$37.4B+24.0%	$30.1B-16.6%	$36.1B+30.0%	$27.8B-6.9%	$29.8B
Cash & Equivalents	$7.5B-3.5%	$7.8B+32.0%	$5.9B+16.6%	$5.1B-50.1%	$10.2B+120.4%	$4.6B
Inventory	$6.7B+18.5%	$5.6B+18.2%	$4.8B+28.3%	$3.7B+17.6%	$3.2B+18.9%	$2.7B
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$44.4B+0.3%	$44.3B-3.4%	$45.8B0.0%	$45.8B+2.6%	$44.6B+0.1%	$44.6B
Total Liabilities	$114.6B+7.7%	$106.4B+7.3%	$99.1B-8.0%	$107.7B+2.5%	$105.1B-4.8%	$110.4B
Current Liabilities	$58.0B+19.0%	$48.7B+18.2%	$41.2B-5.4%	$43.6B+21.0%	$36.0B-10.3%	$40.1B
Long-Term Debt	$28.9B+2.8%	$28.2B+0.2%	$28.1B-9.7%	$31.1B+5.3%	$29.5B-7.4%	$31.9B
Total Equity	$41.0B-11.2%	$46.2B+3.5%	$44.7B-5.2%	$47.1B-6.4%	$50.3B+11.0%	$45.3B
Retained Earnings	$43.5B+4.5%	$41.7B+9.8%	$37.9B+16.4%	$32.6B+14.1%	$28.6B+41.7%	$20.2B

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$157.9B+4.1%	$151.7B+0.7%	$150.7B-3.4%	$155.9B+0.3%	$155.4B+1.5%	$153.1B+0.2%	$152.8B+2.1%	$149.6B
Current Assets	$46.7B+4.5%	$44.7B+2.7%	$43.6B-10.9%	$48.9B+5.7%	$46.2B+6.6%	$43.4B+16.1%	$37.4B+8.2%	$34.5B
Cash & Equivalents	$6.0B+39.2%	$4.3B-48.1%	$8.3B+10.4%	$7.5B+11.2%	$6.8B-19.6%	$8.4B+7.9%	$7.8B-7.9%	$8.5B
Inventory	$5.6B-5.6%	$6.0B+15.3%	$5.2B-22.7%	$6.7B+29.4%	$5.2B+11.7%	$4.6B-18.0%	$5.6B+27.8%	$4.4B
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$44.9B+1.2%	$44.4B0.0%	$44.4B0.0%	$44.4B+0.3%	$44.3B0.0%	$44.3B0.0%	$44.3B-3.4%	$45.8B
Total Liabilities	$115.9B+4.2%	$111.2B+0.9%	$110.2B-3.8%	$114.6B+0.6%	$113.9B+1.9%	$111.8B+5.0%	$106.4B+2.4%	$103.9B
Current Liabilities	$56.5B-0.6%	$56.8B+1.9%	$55.7B-3.9%	$58.0B+4.7%	$55.4B+6.5%	$52.0B+6.7%	$48.7B+3.5%	$47.1B
Long-Term Debt	$30.9B+16.9%	$26.5B+0.1%	$26.5B-8.6%	$28.9B-4.1%	$30.2B-2.8%	$31.1B+10.3%	$28.2B+0.2%	$28.1B
Total Equity	$41.8B+4.0%	$40.2B0.0%	$40.2B-2.0%	$41.0B-0.7%	$41.3B+0.4%	$41.2B-10.9%	$46.2B+1.2%	$45.7B
Retained Earnings	$47.0B+3.2%	$45.6B+2.5%	$44.4B+2.1%	$43.5B+3.3%	$42.1B+2.8%	$41.0B-1.6%	$41.7B+1.6%	$41.0B

CI Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$10.4B-12.3%	$11.8B+36.5%	$8.7B+20.4%	$7.2B-30.5%	$10.3B+9.1%	$9.5B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$1.1B
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	$8.4B
Investing Cash Flow	-$2.1B+59.4%	-$5.2B-267.0%	$3.1B+185.8%	-$3.6B-221.3%	$3.0B+505.4%	-$734.0M
Financing Cash Flow	-$7.6B-78.1%	-$4.3B+61.8%	-$11.2B-36.9%	-$8.2B+3.8%	-$8.5B-18.7%	-$7.2B
Dividends Paid	$1.6B+8.1%	$1.4B+4.8%	$1.4B+3.2%	$1.3B+8840.0%	$15.0M0.0%	$15.0M
Share Buybacks	$7.0B+208.0%	$2.3B-70.0%	$7.6B-1.7%	$7.7B+91.5%	$4.0B+103.4%	$2.0B

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$3.4B+281.2%	-$1.9B-198.2%	$1.9B-63.2%	$5.2B+1866.8%	$265.0M-94.5%	$4.8B+229.9%	$1.5B-48.1%	$2.8B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$4.4B-450.4%	-$797.0M-166.6%	$1.2B+726.7%	-$191.0M+70.2%	-$640.0M-29.3%	-$495.0M-12.5%	-$440.0M+67.1%	-$1.3B
Financing Cash Flow	$2.7B+299.5%	-$1.3B+63.8%	-$3.7B-13.3%	-$3.2B-40.7%	-$2.3B+8.7%	-$2.5B-102.3%	-$1.3B+51.4%	-$2.6B
Dividends Paid	$402.0M+0.2%	$401.0M-2.7%	$412.0M+7.3%	$384.0M-2.0%	$392.0M-2.2%	$401.0M+12.0%	$358.0M-1.1%	$362.0M
Share Buybacks	$0-100.0%	$1.1B-26.3%	$1.5B-25.4%	$2.0B+104.2%	$990.0M-75.4%	$4.0B+639.3%	$544.0M-12.8%	$624.0M

CI Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	3.8%-0.6pp	4.4%-0.3pp	4.7%+0.1pp	4.6%-0.5pp	5.1%-0.2pp	5.3%
Net Margin	1.5%-1.2pp	2.8%-1.0pp	3.8%+0.7pp	3.1%-2.2pp	5.3%+2.0pp	3.3%
Return on Equity	9.2%-2.4pp	11.6%-3.6pp	15.2%+3.7pp	11.5%-5.4pp	16.9%+5.6pp	11.3%
Return on Assets	2.4%-1.1pp	3.5%-1.2pp	4.7%+1.2pp	3.5%-2.0pp	5.5%+2.2pp	3.3%
Current Ratio	0.84+0.1	0.77+0.0	0.73-0.1	0.83+0.1	0.77+0.0	0.74
Debt-to-Equity	0.71+0.1	0.61-0.0	0.63-0.0	0.66+0.1	0.59-0.1	0.70
FCF Margin	N/A	N/A	N/A	N/A	N/A	5.5%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	3.7%+0.3pp	3.4%+0.4pp	3.0%-0.3pp	3.3%-0.7pp	4.0%+0.1pp	3.9%-0.1pp	4.0%-0.5pp	4.6%
Net Margin	2.8%+0.4pp	2.4%+0.3pp	2.1%-0.2pp	2.3%-0.3pp	2.7%+3.1pp	-0.4%-2.5pp	2.2%-0.8pp	2.9%
Return on Equity	4.7%+0.7pp	4.1%+0.6pp	3.5%-0.2pp	3.7%-0.2pp	3.9%	N/A	2.4%-0.8pp	3.2%
Return on Assets	1.3%+0.2pp	1.1%+0.1pp	0.9%-0.1pp	1.0%-0.1pp	1.1%+1.2pp	-0.1%-0.9pp	0.7%-0.3pp	1.0%
Current Ratio	0.83+0.0	0.790.0	0.78-0.1	0.840.0	0.830.0	0.83+0.1	0.77+0.0	0.73
Debt-to-Equity	0.74+0.1	0.660.0	0.66-0.0	0.71-0.0	0.73-0.0	0.75+0.1	0.610.0	0.61
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: The current ratio is below 1.0 (0.84), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Cvs Health Corp CVS

$99.8B

Elevance Health Inc ELV

$76.5B

Humana HUM

$22.1B

Centene Corp Del CNC

$20.0B

Molina Hlthcare MOH

$7.0B

Frequently Asked Questions

What is Cigna Group's annual revenue?

Cigna Group (CI) reported $247.1B in total revenue for fiscal year 2024. This represents a 26.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cigna Group's revenue growing?

Cigna Group (CI) revenue grew by 26.6% year-over-year, from $195.3B to $247.1B in fiscal year 2024.

Is Cigna Group profitable?

Yes, Cigna Group (CI) reported a net income of $3.8B in fiscal year 2024, with a net profit margin of 1.5%.

What is Cigna Group's earnings per share (EPS)?

Cigna Group (CI) reported diluted earnings per share of $12.12 for fiscal year 2024. This represents a -30.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Cigna Group's EBITDA?

Cigna Group (CI) had EBITDA of $12.2B in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cigna Group have?

As of fiscal year 2024, Cigna Group (CI) had $7.5B in cash and equivalents against $28.9B in long-term debt.

What is Cigna Group's operating margin?

Cigna Group (CI) had an operating margin of 3.8% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Cigna Group's net profit margin?

Cigna Group (CI) had a net profit margin of 1.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does Cigna Group pay dividends?

Yes, Cigna Group (CI) paid $5.60 per share in dividends during fiscal year 2024.

What is Cigna Group's return on equity (ROE)?

Cigna Group (CI) has a return on equity of 9.2% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Cigna Group's operating cash flow?

Cigna Group (CI) generated $10.4B in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Cigna Group's total assets?

Cigna Group (CI) had $155.9B in total assets as of fiscal year 2024, including both current and long-term assets.

Does Cigna Group buy back shares?

Yes, Cigna Group (CI) spent $7.0B on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does Cigna Group have outstanding?

Cigna Group (CI) had 274M shares outstanding as of fiscal year 2024.

What is Cigna Group's current ratio?

Cigna Group (CI) had a current ratio of 0.84 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Cigna Group's debt-to-equity ratio?

Cigna Group (CI) had a debt-to-equity ratio of 0.71 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cigna Group's return on assets (ROA)?

Cigna Group (CI) had a return on assets of 2.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Cigna Group's Altman Z-Score?

Cigna Group (CI) has an Altman Z-Score of 2.51, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cigna Group's Piotroski F-Score?

Cigna Group (CI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cigna Group's earnings high quality?

Cigna Group (CI) has an earnings quality ratio of 2.74x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cigna Group cover its interest payments?

Cigna Group (CI) has an interest coverage ratio of 6.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Cigna Group?

Cigna Group (CI) scores 51 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.